Ubs Group Ag Evogene Ltd. Call Options Transaction History
Ubs Group Ag
- $400 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding EVGN
# of Institutions
26Shares Held
3.9MCall Options Held
400Put Options Held
0-
Silverarc Capital Management, LLC3.08MShares$7.05 Million0.57% of portfolio
-
Morgan Stanley New York, NY218KShares$500,2610.0% of portfolio
-
Eidelman Virant Capital117KShares$267,9300.07% of portfolio
-
Lpl Financial LLC Fort Mill, SC67.3KShares$154,1970.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA61.4KShares$140,4930.0% of portfolio
About Evogene Ltd.
- Ticker EVGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,202,000
- Market Cap $94.4M
- Description
- Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...